Zheng T, Wang HY, Chen Y, Chen X, Wu ZL, Hu QY, et al
this likely explains why its less likely to cause nausea compared to other GLP-1 medicines
Semaglutide dosing protocol The standard semaglutide titration for weight management follows a well-established 16-20 week escalation schedule: Weeks 1-4: 0.25 mg once weekly Weeks 5-8: 0.50 mg once weekly Weeks 9-12: 1.0 mg once weekly Weeks 13-16: 1.7 mg once weekly Week 17 onward: 2.4 mg once weekly (maintenance dose) This graduated approach serves two purposes
Trial populations and endpoints vary, and outcomes vary individually
Factors that clinicians typically evaluate include baseline hormone status, medical history, current medications, contraindications such as active malignancies or uncontrolled diabetes, and individual health goals
Its effects surpass digestive functions, potentially impacting pathways within the central nervous system that regulate appetite control and reward systems